NASDAQ:IONS

Ionis Pharmaceuticals Earning Date

USA |NASDAQ |USD

IONS Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 3, 2021 Sep 2021 $-0.51 $-0.26 $-0.22
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 3, 2021 Sep 2021 $158.38M $125.75M $160.08M

Ionis Pharmaceuticals's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 2021.

IONS Earnings Date & History Chart

IONS Earnings & Revenue Forecast

IONS Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 16 $-0.16 $-0.48 $0.20
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 19 $-1.88 $-2.50 $-1.38
Dec 2022 19 $-1.73 $-4.03 $-0.17

IONS Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 3 / 4 $-0.15 $-0.17 $-0.22
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 3 / 0 $-1.84 $-1.87 $-1.90
Dec 2022 4 / 4 $-1.76 $-1.87 $-1.83

IONS Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 15 $213.96M $176.40M $244.28M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 19 $614.97M $595.00M $645.00M
Dec 2022 19 $638.53M $457.24M $814.90M

IONS Earnings Date & Revenue History

IONS Earnings History

|
Show More
Show More

IONS Revenue History

|
Show More
Show More

Ionis Pharmaceuticals Next Earnings Date & Report

IONS Next Earnings Date & Report Preview: Sep 2021 (FQ)

IONS's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 16 analysts, the average EPS estimation for Ionis Pharmaceuticals's next quarterly earnings is $-0.51, with a low EPS estimation of $-0.81, and a high estimation of $-0.14.

Over the last 1 month, EPS estimates have seen 2 upward revisions and 0 downward. The EPS 1 month trend is $-0.46, the last 2 month trend is $-0.48, and the 3 month trend is $-0.44.

Based on 15 analysts, the average revenue estimation is $158.38M, with a low revenue estimation of $143.50M, and a high estimation of $184.80M.

Ionis Pharmaceuticals Previous Earnings Dates & Reports

IONS Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Ionis Pharmaceuticals's previous earnings date was Aug 4, 2021 for its fiscal quarter ended Jun 30, 2021.

IONS's earnings per share (EPS) was $-0.26, beating the consensus analysts forecast of $-0.32 by 19.03%.

The EPS was higher than the previous fiscal quarter (Mar 2021) by -19.99%, and lower than the same period a year before (Jun 2020) by 11.00%.

Revenues were $125.75M, worse than the forecast of $126.00M by -0.20%, up by 12.67% from the previous quarter , and down by -13.60% from the same period last year.

The company reported a net income of $-80.88M.

Free cash flow for the quarter was $-68.96M , compared to $-57.66M last quarter and $-55.36M a year before.

IONS ended the quarter with $1.31B in total debt, an increase of 39.36% compared to the previous quarter, and an increase of 61.95% compared to the same quarter a year before.

IONS Previous Earnings Date & Report Recap: Dec 2020 (FY)

Ionis Pharmaceuticals's previous annual earnings date was Feb 24, 2021 for its fiscal year ended Dec 31, 2020.

IONS's earnings per share (EPS) was $-0.36, beating the consensus analysts forecast of $-0.48 by -25.60% , and lower than the previous year's EPS (Dec 2019) by -116.84%.

Revenues were $729.26M, better than the forecast of $713.19M by 2.25%, and down by -35.04% from previous year's revenue.

The company reported a net income of $-451.29M.

Ionis Pharmaceuticals reported a free cash flow of $-5.16M for its fiscal year, compared to $309.44M a year ago.

The company ended the fiscal year with $839.57M in total debt, an increase of 6.61% compared to the previous year.